Clinical Trials in Miami

Showing 10381-10400 of 11,431 trials

Study to Evaluate SID 530 Compared to Taxotere

NCT00931008

This is a multi-center, randomized, blinded, two-period, two-sequence, crossover study, with a minimum 3-week washout period between treatments.The study is designed to evaluate the bioequivalence of SID530 to Taxotere. It will be conducted in study participants with locally advanced or metastatic NSCLC who have failed platinum therapy and also in participants with locally advanced or metastatic breast cancer who have failed at least one line of chemotherapy. Eligible study participants must be planning to have at least two consecutive 21-day cycles with 75 mg/m2 docetaxel monotherapy. The duration of study participation will be approximately 7 weeks. The study has three study phases: Screening (\<=1 week), Cycle 1 (21 days), and Cycle 2 (21 days).

Non-Small Cell Lung Cancer

SK Chemicals Co., Ltd.42 participantsStarted Oct 2009

Miami, Florida, United States • Canton, Ohio, United States • Vijayawada AndhraPradesh, Ch. Venkatka Krishnayya, India +1 more locations

COMPLETEDPhase 3< 1 mile

Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

NCT00613002

This study is a randomized, double-blind, placebo-controlled, multi-center study of the safety and efficacy of LibiGel® 300mcg in the treatment of HSDD in surgically menopausal women

Hypoactive Sexual Desire Disorder

BioSante Pharmaceuticals597 participantsStarted Dec 2006

Birmingham, Alabama, United States • Hoover, Alabama, United States • Huntsville, Alabama, United States +60 more locations

Study to Evaluate SID 530 Compared to Taxotere

Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

Find Trials by Condition in Miami

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

A Long-Term, Open-Label, Study on Schizophrenia

Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis

Trial of Linaclotide in Patients With Chronic Constipation

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy

Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?

S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Rollover Protocol for Prior SU011248 Protocols

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma